[Corrections] Correction to Lancet Rheumatol 2025; 7: e747

The Lancet Rheumatology. Psoriatic arthritis: strategy shaping treatment. Lancet Rheumatol 2025; 7: e747—In this Editorial, in the third sentence of the third paragraph and in the margin link, the trial name should have read “TICOPA”. Additionally, the final sentence of the fifth paragraph should have read “While GRAPPA distinguishes between complex-to-manage and treatment-refractory disease, EULAR defines difficult-to-manage psoriatic arthritis as persistent disease despite optimal therapy and problematic disease burden by the patient or clinician.” These corrections have been made as of Oct 29, 2025.